Merck's ( NYSE: MRK) experimental antibody drug conjugate zilovertamab vedotin, in combination with standard of care, ...

Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, announced that it will showcase its latest research ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

MET is a tyrosine kinase receptor that has an essential role in normal cell development ... Datroway is comprised of a humanised anti-TROP2 IgG1 monoclonal antibody, developed in collaboration with ...

Such treatment forms innovatively designed prove excellent for selectively targeting HER2 receptors ... innovations include antibody-drug conjugates such as Enhertu (trastuzumab deruxtecan), and ...

Overexpression of the RON receptor tyrosine kinase exists in various cancers and contributes ... were formulated followed by postinsertion of monoclonal antibodies Zt/g4, Zt/c1, or their Fab fragments ...

Discoidin domain receptors (DDRs ... Figure 1. DDR1 kinase activity is necessary for SMC migration to collagen but not for SMC attachment to collagen. A, Western blot probed with an anti-DDR1 antibody ...